Evidence map›Paper›PMID 42255639›Full record

ReviewACS omega2026

AI-Driven Image Analysis for Nanofiber Characterization: From Diameter Measurement to Multiparameter Assessment.

Serdar Tort, Haticenur Negiz, Emre Tunçel, Güliz Demirezen, Mustafa Umut Demirezen

Abstract readReview
In one paragraph

Review in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Serdar TortDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Gazi University, Ankara 06330, Türkiye.ORCID https://orcid.org/0000-0003-4945-5420
Haticenur NegizDepartment of Pharmaceutical Technology, Faculty of Pharmacy, Gazi University, Ankara 06330, Türkiye.ORCID https://orcid.org/0009-0009-7384-4881
Emre TunçelTurkish Medicines and Medical Devices Agency, Ankara 06520, Türkiye.
Güliz DemirezenArtificial Intelligence Policies Association (AIPA), Ankara 06800, Türkiye.
Mustafa Umut DemirezenHuawei R&D Center, MSDC Department, İstanbul 34800, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high surface area and porosity of the nanofibers enable a wide range of pharmaceutical applications, including tissue scaffolds, wound dressings, and drug-loaded films, as well as applications in other fields such as energy, electronics, and environmental remediation. The properties of nanofibers are directly dependent on the production parameters, such as applied voltage, solution flow rate, polymer concentration, solvent type, and collector distance, and there is a complex interplay between these parameters that makes their optimization challenging. Therefore, accurate determination of nanofiber properties, especially fiber diameter, is essential for quality control, process optimization, and functional performance assessment. This review systematically investigates computational methodologies employed in the characterization of nanofibers, with a particular focus on the measurement of fiber diameter. Initially, manual measurements and open-source tools such as DiameterJ, GIFT, and SIMpoly are described, highlighting their advantages and limitations. Subsequently, artificial intelligence-based strategies are described, ranging from classical machine learning models to deep learning architectures, as well as more advanced approaches such as generative frameworks and transformer-based models. In addition, comparisons with traditional characterization methods, industry applications including smart manufacturing, and automated quality control are outlined. Finally, the review examines emerging and prospective artificial intelligence methodologies in the analysis of nanofibers, offering conclusions and recommendations.

Identifiers

PMID42255639
PMCPMC13234637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.